Annals of Oncology

in this issue:

in this issue
Annals of Oncology Advance Access published on October 16, 2006
Ann Oncol 17: 1609; doi:10.1093/annonc/mdl405
[Extract] [Full Text] [PDF] [Request Permissions]

editorial:

BBY Ma and ATC Chan

Transcriptional profiling of tumor biopsies in oncology trials—a ‘window’ of opportunity for evaluating new drugs in nasopharyngeal cancer?
Ann Oncol 17: 1611-1613; doi:10.1093/annonc/mdl416
[Extract] [Full Text] [PDF] [Request Permissions]

reviews:

R Hassan, R Alexander, K Antman, P Boffetta, A Churg, D Coit, P Hausner, R Kennedy, H Kindler, M Metintas, L Mutti, M Onda, H Pass, A Premkumar, V Roggli, D Sterman, P Sugarbaker, R Taub, and C Verschraegen

Current treatment options and biology of peritoneal mesothelioma: meeting summary of the first NIH peritoneal mesothelioma conference
Annals of Oncology Advance Access published on April 6, 2006
Ann Oncol 17: 1615-1619; doi:10.1093/annonc/mdl060
[Abstract] [Full Text] [PDF] [Request Permissions]

C Massard, E Deutsch, and J-C Soria

Tumour stem cell-targeted treatment: elimination or differentiation
Annals of Oncology Advance Access published on May 3, 2006
Ann Oncol 17: 1620-1624; doi:10.1093/annonc/mdl074
[Abstract] [Full Text] [PDF] [Request Permissions]

original articles:

head and neck cancer:

RA Soo, J Wu, A Aggarwal, Q Tao, W Hsieh, T Putti, KB Tan, WL Soon, YF Lai, B Mow, S Hsu, KS Loh, L Tan, P Tan, and B-C Goh

Celecoxib reduces microvessel density in patients treated with nasopharyngeal carcinoma and induces changes in gene expression
Annals of Oncology Advance Access published on September 28, 2006
Ann Oncol 17: 1625-1630; doi:10.1093/annonc/mdl283
[Abstract] [Full Text] [PDF] [Request Permissions]

breast cancer:

R Ponzone, F Montemurro, F Maggiorotto, C Robba, D Gregori, ME Jacomuzzi, F Kubatzki, D Marenco, A Dominguez, N Biglia, and P Sismondi

Clinical outcome of adjuvant endocrine treatment according to PR and HER-2 status in early breast cancer
Annals of Oncology Advance Access published on September 15, 2006
Ann Oncol 17: 1631-1636; doi:10.1093/annonc/mdl296
[Abstract] [Full Text] [PDF] [Request Permissions]

B Moy, D Tu, JL Pater, JN Ingle, LE Shepherd, TJ Whelan, and PE Goss

Clinical outcomes of ethnic minority women in MA.17: a trial of letrozole after 5 years of tamoxifen in postmenopausal women with early stage breast cancer
Annals of Oncology Advance Access published on August 25, 2006
Ann Oncol 17: 1637-1643; doi:10.1093/annonc/mdl177
[Abstract] [Full Text] [PDF] [Request Permissions]

I Blancas, JL García-Puche, B Bermejo, EO Hanrahan, C Monteagudo, A Martínez-Agulló, R Rouzier, BT Hennessy, V Valero, and A Lluch

Low number of examined lymph nodes in node-negative breast cancer patients is an adverse prognostic factor
Annals of Oncology Advance Access published on July 27, 2006
Ann Oncol 17: 1644-1649; doi:10.1093/annonc/mdl169
[Abstract] [Full Text] [PDF] [Request Permissions]

gastrointestinal tumors:

LF de Geus-Oei, B Wiering, PFM Krabbe, TJM Ruers, CJA Punt, and WJG Oyen

FDG-PET for prediction of survival of patients with metastatic colorectal carcinoma
Annals of Oncology Advance Access published on August 25, 2006
Ann Oncol 17: 1650-1655; doi:10.1093/annonc/mdl180
[Abstract] [Full Text] [PDF] [Request Permissions]

M Gusella, G Crepaldi, C Barile, A Bononi, D Menon, S Toso, D Scapoli, L Stievano, E Ferrazzi, F Grigoletto, M Ferrari, and R Padrini

Pharmacokinetic and demographic markers of 5-fluorouracil toxicity in 181 patients on adjuvant therapy for colorectal cancer
Annals of Oncology Advance Access published on September 12, 2006
Ann Oncol 17: 1656-1660; doi:10.1093/annonc/mdl284
[Abstract] [Full Text] [PDF] [Request Permissions]

R Berardi, C Braconi, G Mantello, M Scartozzi, S Del Prete, G Luppi, R Martinelli, M Fumagalli, G Valeri, I Bearzi, C Marmovale, F Grillö-Ruggieri, and S Cascinu

Anemia may influence the outcome of patients undergoing neo-adjuvant treatment of rectal cancer
Annals of Oncology Advance Access published on September 12, 2006
Ann Oncol 17: 1661-1664; doi:10.1093/annonc/mdl285
[Abstract] [Full Text] [PDF] [Request Permissions]

W Ichikawa and Y Sasaki

Correlation between tumor response to first-line chemotherapy and prognosis in advanced gastric cancer patients
Annals of Oncology Advance Access published on July 27, 2006
Ann Oncol 17: 1665-1672; doi:10.1093/annonc/mdl174
[Abstract] [Full Text] [PDF] [Request Permissions]

lung cancer:

T Berghmans, M Paesmans, C Mascaux, B Martin, A-P Meert, A Haller, J-J Lafitte, and J-P Sculier

Thyroid transcription factor 1—a new prognostic factor in lung cancer: a meta-analysis
Annals of Oncology Advance Access published on September 15, 2006
Ann Oncol 17: 1673-1676; doi:10.1093/annonc/mdl287
[Abstract] [Full Text] [PDF] [Request Permissions]

urogenital tumors:

FC Maluf, C Cordon-Cardo, DA Verbel, JM Satagopan, MG Boyle, H Herr, and DF Bajorin

Assessing interactions between mdm-2, p53, and bcl-2 as prognostic variables in muscle-invasive bladder cancer treated with neo-adjuvant chemotherapy followed by locoregional surgical treatment
Annals of Oncology Advance Access published on September 19, 2006
Ann Oncol 17: 1677-1686; doi:10.1093/annonc/mdl289
[Abstract] [Full Text] [PDF] [Request Permissions]

I Boukovinas, N Androulakis, L Vamvakas, P Papakotoulas, N Ziras, A Polyzos, A Kalykaki, A Kotsakis, N Xenidis, I Gioulmbasanis, D Mavroudis, and V Georgoulias

Sequential gemcitabine and cisplatin followed by docetaxel as first-line treatment of advanced urothelial carcinoma: a multicenter phase II study of the Hellenic Oncology Research Group
Annals of Oncology Advance Access published on September 12, 2006
Ann Oncol 17: 1687-1692; doi:10.1093/annonc/mdl286
[Abstract] [Full Text] [PDF] [Request Permissions]

hematologic malignancies:

AK Ng, S Li, D Neuberg, DC Fisher, C McMillan, B Silver, KC Marcus, MA Stevenson, and PM Mauch

Long-term results of a prospective trial of mantle irradiation alone for early-stage Hodgkin's disease
Annals of Oncology Advance Access published on October 3, 2006
Ann Oncol 17: 1693-1697; doi:10.1093/annonc/mdl288
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

quality of life and supportive care:

F Efficace, A Bottomley, EF Smit, P Lianes, C Legrand, C Debruyne, F Schramel, HJ Smit, R Gaafar, B Biesma, C Manegold, C Coens, G Giaccone, and J Van Meerbeeck On behalf of the EORTC Lung Cancer Group and Quality of Life Unit

Is a patient's self-reported health-related quality of life a prognostic factor for survival in non-small-cell lung cancer patients? A multivariate analysis of prognostic factors of EORTC study 08975
Annals of Oncology Advance Access published on September 12, 2006
Ann Oncol 17: 1698-1704; doi:10.1093/annonc/mdl183
[Abstract] [Full Text] [PDF] [Request Permissions]

G Mustacchi, R Ceccherini, C Dellach, S Foladore, S Milani, M Leita, and M Sisto

An induction dose of epoetin of 40 000 IU daily for three consecutive days increases and maintains hemoglobin levels in anemic cancer patients undergoing chemotherapy
Annals of Oncology Advance Access published on September 15, 2006
Ann Oncol 17: 1705-1708; doi:10.1093/annonc/mdl297
[Abstract] [Full Text] [PDF] [Request Permissions]

phase I and pharmacokinetics:

L Gore, SN Holden, RB Cohen, M Morrow, AS Pierson, CL O'Bryant, M Persky, D Gustafson, C Mikule, S Zhang, PA Palmer, and SG Eckhardt

A phase I safety, pharmacological and biological study of the farnesyl protein transferase inhibitor, tipifarnib and capecitabine in advanced solid tumors
Annals of Oncology Advance Access published on September 15, 2006
Ann Oncol 17: 1709-1717; doi:10.1093/annonc/mdl282
[Abstract] [Full Text] [PDF] [Request Permissions]

letters to the editor:

JWB de Groot, TP Links, and WTA van der Graaf

Tyrosine kinase inhibitors causing hypothyroidism in a patient on levothyroxine
Annals of Oncology Advance Access published on May 26, 2006
Ann Oncol 17: 1719-1720; doi:10.1093/annonc/mdl112
[Extract] [Full Text] [PDF] [Request Permissions]

D Errante, D Bernardi, A Bianco, S De Nardi, and L Salvagno

Rituximab-related urticarial reaction in a patient treated for primary cutaneous B-cell lymphoma
Annals of Oncology Advance Access published on May 26, 2006
Ann Oncol 17: 1720-1721; doi:10.1093/annonc/mdl113
[Extract] [Full Text] [PDF] [Request Permissions]

AJM Ferreri, M Ponzoni, GP Dognini, M-Q Du, C Doglioni, J Radford, R Dolcetti, and F Cavalli

Bacteria-eradicating therapy for ocular adnexal MALT lymphoma: questions for an open international prospective trial
Annals of Oncology Advance Access published on June 7, 2006
Ann Oncol 17: 1721-1722; doi:10.1093/annonc/mdl124
[Extract] [Full Text] [PDF] [Request Permissions]

G Jäger, P Neumeister, F Quehenberger, S Wöhrer, W Linkesch, and M Raderer

Prolonged clinical remission in patients with extranodal marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue type treated with cladribine: 6 year follow-up of a phase II trial
Annals of Oncology Advance Access published on June 9, 2006
Ann Oncol 17: 1722-1723; doi:10.1093/annonc/mdl126
[Extract] [Full Text] [PDF] [Request Permissions]

RS de Vries, EJ Mattijssen, and AA van Sorge

Serious delayed hypersensitivity reaction to oxaliplatin
Annals of Oncology Advance Access published on June 6, 2006
Ann Oncol 17: 1723-1724; doi:10.1093/annonc/mdl116
[Extract] [Full Text] [PDF] [Request Permissions]

K Hotta and K Kiura

Role of platinum-based radio-chemotherapy for locally advanced non-small-cell lung cancer: possible influence of type of platinum on survival data
Annals of Oncology Advance Access published on June 21, 2006
Ann Oncol 17: 1724; doi:10.1093/annonc/mdl130
[Extract] [Full Text] [PDF] [Request Permissions]

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.